FiercePharma

Xeris, a rival to Lilly and Novo, gets FDA nod for glucagon kit

Xeris Pharmaceuticals has opened another front in its fight to win market share from Eli Lilly and Novo Nordisk with the FDA approval of its Gvoke Kit for the treatment of severe hypoglycemia. Chicago ...
Charlotte Observer

A recalled emergency blood sugar kit failed. This caused seizures and can cause death

Eli Lilly recalled an emergency kit that can save the lives of people with diabetes having severe hypoglycemia. The reason: “loss of potency” after the kit failed a customer who needed it. Here’s what ...
Business Wire

Xeris Pharmaceuticals Announces Approval of Supplemental New Drug Application (sNDA) of Gvoke® Kit for the Treatment of Severe Hypoglycemia

CHICAGO--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use ...
FierceBiotech

Biodel Announces Development Plans to Commercialize Glucagon Rescue Product Candidate for the Treatment of Severe Hypoglycemia

DANBURY, Conn., June 6, 2013 (GLOBE NEWSWIRE) -- Biodel Inc. (BIOD) today announced plans to submit a New Drug Application (NDA) to the FDA in 2015 for a novel glucagon rescue device to treat severe ...
Business Wire

Fresenius Kabi Introduces Glucagon Emergency Medicine Kit to Treat Life-Threatening Episodes of Low Blood Sugar

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today the availability in the United States of its Glucagon Emergency Kit, an FDA-approved and cost-effective alternative to treat severe ...